Fri.May 03, 2024

article thumbnail

CDC’s top flu scientist says the risk to the public from H5N1 is low, but she isn’t sleeping well. Here’s why

STAT

Vivien Dugan isn’t getting much sleep these days. The director of the influenza division at the Centers for Disease Control and Prevention, Dugan is leading the team of CDC scientists that is working with partners — in the U.S. Department of Agriculture, the Food and Drug Administration, and state and local health departments — to respond to the H5N1 bird flu outbreak in dairy cattle.

364
364
article thumbnail

Takeover target? Activist investor believes Novavax tech would be in ‘better hands’ with Big Pharma

PharmaVoice

With its next earnings report looming, pushback from an investor is adding pressure on Novavax to boost performance.

183
183
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Texas dairy farm worker’s case may be first where bird flu virus spread from mammal to human, scientists say

STAT

A new report on the first human bird flu case tied to the outbreak in cows in the United States suggests that the Texas man may be the first detected case of the H5N1 virus transmitting from a mammal to a person. Nearly 900 people in 23 countries have been infected with the H5N1 bird flu virus since it started spreading from Southeast Asia in late 2003.

363
363
article thumbnail

International phase 3 clinical trial for new melanoma treatment recruits first patients

Pharma Times

The INTerpath-001 trial is evaluating Moderna/Merck’s mRNA-4157 in combination with Merck’s Keytruda

Hospitals 150
article thumbnail

Navigating Payroll Compliance: Future-Proofing Payroll in an Evolving Regulatory Landscape

Speaker: Jennifer Hill

Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.

article thumbnail

New Medicaid rule expected to lower wait times for home-based care, raise caregiver wages

STAT

Caregivers for older adults and people with disabilities could see a bump in their wages in the coming years, thanks to a forthcoming rule by the Centers for Medicare and Medicaid Services. The new rule brings sweeping changes to a bevy of Medicaid programs throughout the country, including fee-for-service and managed care delivery systems. One of the most notable changes applies to the home and community-based services (HCBS) industry.

362
362

More Trending

article thumbnail

Opinion: An AI-based second opinion service could improve clinical decision-making today

STAT

Millions of Americans rely on the internet to answer questions about their own health. The public release of powerful artificial intelligence models like ChatGPT has only accelerated these trends. In a large survey , more than half of American adults reported putting their own health information into a large language model (LLM). And there’s reason to believe these models might bring real value to these people, such as the case of a mother who, after seeing 17 physicians and receiving no

359
359
article thumbnail

Boehringer will use Walgreens trials unit for obesity trial

pharmaphorum

Walgreens’ plans to disrupt the clinical trials sector have taken a step forward with a high-profile partnership with Boehringer Ingelheim

133
133
article thumbnail

STAT+: 4 burning questions about Amgen’s obesity drug, a potential Wegovy and Zepbound competitor

STAT

Amgen’s comments Thursday that it’s “very encouraged” by interim Phase 2 data for its obesity drug have quickly sparked immense investor interest in what could be a potential contender with Novo Nordisk’s Wegovy and Eli Lilly’s Zepbound. The injectable drug MariTide, designed to be given monthly, could be a more attractive option than Wegovy and Zepbound, which are both dosed weekly.

348
348
article thumbnail

Have your say on PCN pharmacy and you could win a £200 voucher

The Pharmacist

Together with our sister publications, The Pharmacist has launched a survey to hear what pharmacists think about the last five years of change in primary care. The State of Primary Care Survey asks how the changes to the NHS — the launch of primary care networks (PCNs) in 2019 and the shift to integrated care systems (ICSs) in 2022 […] The post Have your say on PCN pharmacy and you could win a £200 voucher appeared first on The Pharmacist.

130
130
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Statehouses are a hotbed of tobacco lobbying and legislation

STAT

WASHINGTON — Around the country, s tatehouses from Harrisburg, Penn. to Tallahassee, Fla., are being flooded with tobacco industry lobbyists, according to a new report from the anti-smoking advocacy group Action on Smoking and Health.  There are now at least 950 lobbyists representing cigarette, vape, and snus companies in statehouses around the country, according to the latest edition of the group’s Tobacco Industry Lobbyist and Lobbying Firm Registration Tracker, which was r

300
300
article thumbnail

Apple gets FDA okay to use AFib tool in clinical trials

pharmaphorum

Apple gets FDA okay to use the atrial fibrillation history tool incorporated in some of its Apple Watch devices in clinical trials

126
126
article thumbnail

STAT+: Senate drug shortage bill would pay hospitals bonuses for good contracting practices

STAT

WASHINGTON — The Senate Finance Committee has drafted a bipartisan bill to mitigate drug shortages by rewarding hospitals for business practices that ensure an adequate supply of drugs. Drug shortages have been a persistent problem for years, and they’re worse than ever, according to a recent report by the American Society of Health-System Pharmacists.

Hospitals 300
article thumbnail

CG follows big IPO with new results for bladder cancer drug

BioPharma Dive

Newly disclosed Phase 3 results presented Friday match findings the biotech disclosed last year, while offering a more comprehensive look at how its drug stacks up to rival therapies.

120
120
article thumbnail

Why Every Small Business Needs an HCM Solution: A Comprehensive Guide

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

article thumbnail

Opinion: Virtual first is flaming out. A virtual-second model can refresh telehealth

STAT

Telehealth needs a major refresh. Just this week, retail juggernaut Walmart announced it is shuttering its virtual care business. Not long before that, Optum announced the closing of Optum Virtual Care , Teladoc Health announced a change in leadership following a further drop in stock price , and the Peterson Health Technology Institute published a report critical of outcomes generated by most digital diabetes management providers.

Diabetes 294
article thumbnail

Antipsychotics associated with much wider harms in dementia patients than thought

The Pharmacist

Use of antipsychotic medications in patients with dementia is linked with a much wider range of serious harms than previously thought, UK researchers have said. Although there have been safety warnings on use of the antipsychotics from regulators about increased risk of stroke and death, a large study has now found increased risks for pneumonia, […] The post Antipsychotics associated with much wider harms in dementia patients than thought appeared first on The Pharmacist.

118
118
article thumbnail

Opinion: People like me with bipolar disorder must help shape research and clinical care

STAT

Doctors have observed and treated bipolar disorder for thousands of years. Known throughout history by many names, like depression, mania, manic-depressive illness, or psychosis, the disorder is common and closely tied to that which makes us human: our thinking, our behavior, our hopes, and our ambitions. A solid foundation of science grounds the understanding of bipolar disorder; what’s lacking are strong data about the experience of people with the condition.

294
294
article thumbnail

Price cut unlocks NHS use of sickle cell drug Oxbryta

pharmaphorum

Some NHS patients in the UK will finally be able to access Pfizer’s sickle cell disease therapy Oxbryta after agreement was reached on a price cut

118
118
article thumbnail

Best Practices to Streamline Compensation Management: A Foundation for Growth

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

article thumbnail

ICER casts doubt on Sarepta’s DMD gene therapy

STAT

Want to stay on top of the science and politics driving biotech today?  Sign up  to get our biotech newsletter in your inbox. Good morning! A crowdsourced Readout today, to be sure, with contributions from STAT’s Jason Mast, Elaine Chen, and Jonathan Wosen. We get into earnings from Novo Nordisk, Amgen, and Illumina, and see that ICER is not so enthused about a gene therapy from Sarepta.

article thumbnail

Pharmacy concerns after data reveals drop in Welsh GP practices

The Pharmacist

A decline in the number of GP practices in Wales has prompted the Royal Pharmaceutical Society (RPS) to call for government investment, amid concern over the ability of pharmacists working in general practice to deliver high-quality care. Official figures show there were 374 active GP practices in Wales at the end of 2023, which represents […] The post Pharmacy concerns after data reveals drop in Welsh GP practices appeared first on The Pharmacist.

118
118
article thumbnail

STAT+: Pharmalittle: We’re reading about an Amgen obesity drug, a Senate bill on shortages, and more

STAT

And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is still on the drawing board, but we do plan to catch some outdoor sounds, promenade with the official mascots, manicure the grounds, and hold another listening party, where the rotation will likely include this , this , this , this and this.

article thumbnail

‘Our culture is dying’: vulture shortage threatens Zoroastrian burial rites

The Guardian - Pharmaceutical Industry

Inadvertent poisoning of scavengers across Indian subcontinent is forcing some communities to give up ancient custom Traditional Zoroastrian burial rites are becoming increasingly impossible to perform because of the precipitous decline of vultures in India, Iran and Pakistan. For millennia, Parsi communities have traditionally disposed of their dead in structures called dakhma, or “towers of silence”.

111
111
article thumbnail

Enhance Healthcare Efficiency With Top Payroll & HCM Services

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

article thumbnail

STAT+: Up and down the ladder: The latest comings and goings

STAT

Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others.  That’s right. Send us your changes, and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going. And here is our regular feature in which we highlight a different person each week.

246
246
article thumbnail

Amgen shares soar as executives outline obesity drug push

BioPharma Dive

The company said data for its Wegovy competitor was promising enough to move the drug into late-stage testing, triggering a stock jump that added billions to Amgen’s market value.

110
110
article thumbnail

Healthcare AI from Cera ‘could save NHS and UK £1bn a year’

pharmaphorum

AI-powered home healthcare model from Cera could save NHS and UK £1bn in 2026 if adopted nationwide, says new study

108
108
article thumbnail

Pharma Pulse 5/3/24: Compounded, Counterfeit Semaglutide Poses Severe Risk to Patients, Thermo Fisher Scientific Launches New Testing Service & more

Pharmaceutical Commerce

The latest news for pharma industry insiders.

article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Breaking down the challenges of donor recruitment and recallability

pharmaphorum

Donor recruitment and recallability remain key challenges for the disease research community. This post breaks down strategies to engage more healthy donors and boost recall rates.

108
108
article thumbnail

Latus Bio secures $54m for CNS gene therapy development

Pharmaceutical Business Review

The financing round is co-led by 8VC and DCVC Bio, with contributions from Samsung Life Science Fund, The Children’s Hospital of Philadelphia Foundation, Benjamin Franklin Technology Partners, Modi Ventures, and Gaingels. Latus Bio, emerging from the lab of co-founder professor Beverly Davidson at the Children’s Hospital of Philadelphia, is utilising proprietary technologies to develop CNS gene therapy candidates.

Hospitals 105
article thumbnail

FDA grants RMAT designation to Taysha’s Rett syndrome gene therapy 

Pharmaceutical Technology

The FDA has awarded the designation following a review of initial safety and efficacy data from two Phase I/II clinical trials.

105
105